| Phytochemical Name | Triptolide |
| PubChem CID | 107985 |
| Disease Indication | Nonalcoholic steatohepatitis [ICD-11: DB92] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: ABT-199; Carboplatin; Cetuximab; Doxorubicin; Gefitinib |
| Source |
Warm
Tripterygium hypoglaucum;
Cool
Tripterygium wilfordii
|
| Phytochemical Name | Celastrol |
| PubChem CID | 122724 |
| Disease Indication | Solid tumour or cancer [ICD-11: 2A00-2F9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Afatinib; Cisplatin; Docetaxel; Histone deacetylase inhibitor; TNF-related apoptosis inducing ligand; Tamoxifen |
| Source |
Warm
Celastrus orbiculatus
Cool
Tripterygium wilfordii;
|
| Phytochemical Name | Triptonide |
| PubChem CID | 65411 |
| Disease Indication | Nasopharyngeal carcinoma [ICD-11: 2B6B] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Cisplatin |
| Source |
Warm
Tripterygium hypoglaucum;
Cool
Tripterygium wilfordii
|
| Phytochemical Name | Wilforlide A |
| PubChem CID | 158477 |
| Disease Indication | Prostate cancer [ICD-11: 2C82.0] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Docetaxel |
| Source |
Cool
Tripterygium wilfordii
|
| Phytochemical Name | Triptolide |
| PubChem CID | 107985 |
| Disease Indication | Nonalcoholic steatohepatitis [ICD-11: DB92] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: ABT-199; Carboplatin; Cetuximab; Doxorubicin; Gefitinib |
| Source |
Warm
Tripterygium hypoglaucum;
Cool
Tripterygium wilfordii
|
| Phytochemical Name | Celastrol |
| PubChem CID | 122724 |
| Disease Indication | Solid tumour or cancer [ICD-11: 2A00-2F9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Afatinib; Cisplatin; Docetaxel; Histone deacetylase inhibitor; TNF-related apoptosis inducing ligand; Tamoxifen |
| Source |
Warm
Celastrus orbiculatus
Cool
Tripterygium wilfordii;
|
| Phytochemical Name | Triptonide |
| PubChem CID | 65411 |
| Disease Indication | Nasopharyngeal carcinoma [ICD-11: 2B6B] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Cisplatin |
| Source |
Warm
Tripterygium hypoglaucum;
Cool
Tripterygium wilfordii
|
| Phytochemical Name | Wilforlide A |
| PubChem CID | 158477 |
| Disease Indication | Prostate cancer [ICD-11: 2C82.0] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Docetaxel |
| Source |
Cool
Tripterygium wilfordii
|
| Phytochemical Name | Triptolide |
| PubChem CID | 107985 |
| Disease Indication | Nonalcoholic steatohepatitis [ICD-11: DB92] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: ABT-199; Carboplatin; Cetuximab; Doxorubicin; Gefitinib |
| Source |
Warm
Tripterygium hypoglaucum;
Cool
Tripterygium wilfordii
|
| Phytochemical Name | Celastrol |
| PubChem CID | 122724 |
| Disease Indication | Solid tumour or cancer [ICD-11: 2A00-2F9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Afatinib; Cisplatin; Docetaxel; Histone deacetylase inhibitor; TNF-related apoptosis inducing ligand; Tamoxifen |
| Source |
Warm
Celastrus orbiculatus
Cool
Tripterygium wilfordii;
|
